Are You Familiar With Alberta’s Updated Price Policy?

The update touches the Alberta Price Confirmation, the pan-Canadian generic initiative price confirmation, the fixed pricing rule, the least cost alternative policy and the maximum allowable cost policy…Read more. (Source: Canadian Market Access, 2/19/14).

You might also be interested in:

ICER’s Updated Assessment of New Targeted Therapies for… June 13, 2018
HHS Plans to Implement 340B Final Rule in January November 1, 2018
Hospitals, Insurers Eye Drug Rebate Rule April 10, 2019
ICER Releases Final New Evidence Update for Alirocumab February 15, 2019
Time to Market: Accelerating Market Access January 4, 2019
ICER Releases Updated Report on Targeted Treatments for Plaque… August 5, 2018
Research Suggests Low-Cost Generics at High Risk of Shortages December 14, 2018